Improving communication for Spanish-speaking families with cancer
Improving Communication With and Building a Stronger Medical Home Among Spanish-speaking Families in the Center for Cancer and Blood Disorders
This study is trying to improve communication and support for Spanish-speaking families dealing with leukemia or non-Hodgkin lymphoma to help them feel more included and better understand their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | N/A to 22 Years |
| Sex | All |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Trial ID | NCT05425992 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance communication with Spanish-speaking families of patients diagnosed with leukemia or non-Hodgkin lymphoma. The study focuses on increasing the sense of inclusion within the medical community, improving medical knowledge and understanding, and enhancing adherence to treatment regimens. By conducting interviews, the study seeks to address gaps in care and promote equality in the delivery of comprehensive medical services across both physical and psychosocial domains.
Who should consider this trial
Good fit: Ideal candidates include Spanish-speaking patients aged 0 to 22 years diagnosed with leukemia or non-Hodgkin lymphoma who are receiving care at the Center for Cancer and Blood Disorders.
Not a fit: Patients without an oncologic diagnosis or those whose parents prefer English may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better health outcomes and improved quality of care for Spanish-speaking families dealing with cancer.
How similar studies have performed: While there may be similar studies focusing on communication in healthcare, this specific approach targeting Spanish-speaking families in oncology is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 0 to 22 years of age * Diagnosis of leukemia or non-Hodgkin lymphoma * Spanish as preferred language for patient, parent or guardian * Received or receiving care at the Center for Cancer and Blood Disorders (CCBD) Exclusion Criteria: * Patients without oncologic diagnosis * Patients with parents whose language preference is English * Patients who received care solely outside of the CCBD
Where this trial is running
Aurora, Colorado
- Children's Hospital Colorado — Aurora, Colorado, United States (Recruiting)
Study contacts
- Principal investigator: Ashley Rogers — Children's Hospital Colorado
- Study coordinator: Wendy Moore
- Email: wendy.moore@childrenscolorado.org
- Phone: 1-720-777-6353
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.